In the training cohort, univariate analysis and multivariate logistic regression of clinical-laboratory characteristics and Radscore revealed that tumor location, cTNM staging, CEA, CA199, and Radscore were significant predictors for HER2 status of GCs (Table 3). Here, ERBB2 is linked to neoplasm.